当前位置:首页 - 行情中心 - 盟科药业-U(688373) - 财务分析

盟科药业-U

(688373)

  

流通市值:43.56亿  总市值:54.35亿
流通股本:5.25亿   总股本:6.56亿

盟科药业-U(688373)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-1.39亿元,每股收益-0.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益31337.58万元,未分配利润-194336.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产77290.28万元,负债45952.70万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入66,969,753.0933,216,965.04130,272,762.0197,562,309.83
营业总成本209,906,680.3496,412,359.38581,598,318.57394,736,146.75
其他经营收益
营业利润-138,071,955.4-61,631,420.62-434,488,730.84-285,121,099.87
利润总额-138,558,720.03-61,632,475.69-434,511,616.97-285,134,839.3
净利润-138,674,492.55-61,632,475.69-440,721,217.09-291,296,145.99
每股收益
其他综合收益-2,175,638.72-816,039.596,175,113.781,623,228.55
综合收益总额-140,850,131.27-62,448,515.28-434,546,103.31-289,672,917.44
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计681,881,628.84757,668,471.24748,661,957.2869,192,299.77
非流动资产:
非流动资产合计91,021,128.6995,914,956.73100,466,702.42101,557,316.22
资产总计772,902,757.53853,583,427.97849,128,659.62970,749,615.99
流动负债:
流动负债合计255,577,971.57243,116,122.74212,296,583.22128,027,426.86
非流动负债:
非流动负债合计203,949,025.63226,146,768.6197,868,324.69275,068,895.66
负债合计459,526,997.2469,262,891.34410,164,907.91403,096,322.52
所有者权益(或股东权益):
归属于母公司股东权益合计313,375,760.33384,320,536.63438,963,751.71567,653,293.47
股东权益合计313,375,760.33384,320,536.63438,963,751.71567,653,293.47
负债和股东权益合计772,902,757.53853,583,427.97849,128,659.62970,749,615.99
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计74,196,489.7235,560,357.02140,148,380.61102,006,625.4
经营活动现金流出小计194,901,168.587,608,552.25587,329,115.94395,492,556.02
经营活动产生的现金流量净额-120,704,678.78-52,048,195.23-447,180,735.33-293,485,930.62
投资活动产生的现金流量:
投资活动现金流入小计1,395,779,562.05856,791,336.863,007,544,042.271,904,622,936.4
投资活动现金流出小计1,358,240,751.28812,887,455.512,492,745,819.281,565,134,550.13
投资活动产生的现金流量净额37,538,810.7743,903,881.35514,798,222.99339,488,386.27
筹资活动产生的现金流量:
筹资活动现金流入小计71,702,238.6964,479,490.67106,977,035100,000,000
筹资活动现金流出小计24,029,051.287,527,81838,882,257.2626,070,254.51
筹资活动产生的现金流量净额47,673,187.4156,951,672.6768,094,777.7473,929,745.49
汇率变动对现金及现金等价物的影响-934,222.35-102,090.07143,372.07-3,394,068.68
现金及现金等价物净增加额-36,426,902.9548,705,268.72135,855,637.47116,538,132.46
期末现金及现金等价物余额236,905,387.67322,037,559.34273,332,290.62254,014,785.61
补充资料:
现金及现金等价物的净增加额-36,426,902.95-135,855,637.47-
最新报告期:2025-08-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
光大证券叶思奥,王明瑞-0.37-0.31-0.182025-08-27
TOP↑